New annual flu shot alternative shows promise in Long-Term safety trial
NCT ID NCT07225959
First seen Nov 10, 2025 · Last updated Apr 26, 2026 · Updated 13 times
Summary
This study looks at whether giving a new experimental drug called CD388 once a year for two years is safe in healthy adults who have already received one dose without major side effects. About 400 participants will get two doses and be monitored for 18 months. Researchers will check if the body makes antibodies against the drug, watch for side effects, and measure how the drug behaves in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Floridian Clinical Research
Miami Lakes, Florida, 33016, United States
-
Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
-
hVIVO Serviced Limited
London, England, E1 1EQ, United Kingdom
Conditions
Explore the condition pages connected to this study.